Landmark trial
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
Cooper JS, Pajak TF, Forastiere AA, et al.
DoseLab summary
RTOG/Intergroup phase 3 trial of post-operative radiotherapy with or without concurrent cisplatin. Citation checked against Crossref; content not yet reviewed by DoseLab.
Why this is useful
The RTOG companion to EORTC 22931: post-operative cisplatin chemoradiation for high-risk resected head and neck cancer.
Reference details
- Title
- Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
- Authors / organization
- Cooper JS, Pajak TF, Forastiere AA, et al.
- Publication / protocol
- N Engl J Med. 2004;350(19):1937–1944
- Version
- Pending verification
- Year
- 2004
- DOI
- 10.1056/NEJMoa032646
- Disease sites
- Head & Neck
- Topics
- Head & Neck, Post-operative, Chemoradiation, Landmark trial, RTOG
- Fractionation context
- Pending verification
- Last reviewed by DoseLab
- Pending verification